140 related articles for article (PubMed ID: 3460522)
1. Effect of imipenem-cilastatin therapy on fecal flora.
Welkon CJ; Long SS; Gilligan PH
Antimicrob Agents Chemother; 1986 May; 29(5):741-3. PubMed ID: 3460522
[TBL] [Abstract][Full Text] [Related]
2. Effect of imipenem/cilastatin on the colonic microflora.
Nord CE; Kager L; Philipson A; Stiernstedt G
Rev Infect Dis; 1985; 7 Suppl 3():S432-4. PubMed ID: 3863218
[TBL] [Abstract][Full Text] [Related]
3. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside.
Baruchel A; Hartmann O; Andremont A; Tancrède C
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():167-73. PubMed ID: 3469190
[TBL] [Abstract][Full Text] [Related]
4. Imipenem-cilastatin: the first thienamycin antibiotic.
Jacobs RF
Pediatr Infect Dis; 1986; 5(4):444-8. PubMed ID: 3523460
[No Abstract] [Full Text] [Related]
5. A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
Calandra GB; Hesney M; Grad C
Eur J Clin Microbiol; 1984 Oct; 3(5):478-87. PubMed ID: 6389126
[TBL] [Abstract][Full Text] [Related]
6. Early clinical experience with imipenem-cilistatin.
Ellis-Pegler RB; Downey D; Bremner DA
N Z Med J; 1985 Mar; 98(775):188-91. PubMed ID: 3856762
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
Reutter FW
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
[TBL] [Abstract][Full Text] [Related]
8. Imipenem-cilastatin sodium (Primaxin).
Med Lett Drugs Ther; 1986 Mar; 28(709):29-31. PubMed ID: 3512968
[No Abstract] [Full Text] [Related]
9. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.
Calandra GB; Ricci FM; Wang C; Brown KR
J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
Garau J; Casagrán A; Sánchez C; Matas E
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
[TBL] [Abstract][Full Text] [Related]
11. Imipenem/cilastatin for the treatment of infections in hospitalized children.
Alpert G; Dagan R; Connor E; Campos JM; Bloh AM; Powell KR; Plotkin SA
Am J Dis Child; 1985 Nov; 139(11):1153-6. PubMed ID: 3904406
[TBL] [Abstract][Full Text] [Related]
12. The effect of imipenem/cilastatin on the aerobic faecal flora of children.
Borderon JC; Rastegar A; Laugier J; Gold F
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():121-5. PubMed ID: 3102450
[TBL] [Abstract][Full Text] [Related]
13. Impact of imipenem/cilastatin therapy on faecal flora.
Nord CE; Kager L; Philipson A; Stiernstedt G
Eur J Clin Microbiol; 1984 Oct; 3(5):475-7. PubMed ID: 6594237
[TBL] [Abstract][Full Text] [Related]
14. Imipenem/cilastatin as secondary therapy for infections in cancer patients.
Bodey GP; Rolston K; Jones P; Alvarez ME; Fainstein V; Steelhammer L
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():161-6. PubMed ID: 3469189
[TBL] [Abstract][Full Text] [Related]
15. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
Keller CA; Villavicencio J; Ramirez C
Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
[TBL] [Abstract][Full Text] [Related]
16. Impact of imipenem/cilastatin therapy on normal fecal flora.
Wexler HM; Finegold SM
Am J Med; 1985 Jun; 78(6A):41-6. PubMed ID: 3859214
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.
Lode H; Wiley R; Höffken G; Wagner J; Borner K
Antimicrob Agents Chemother; 1987 Oct; 31(10):1491-6. PubMed ID: 3324956
[TBL] [Abstract][Full Text] [Related]
18. Imipenem/cilastatin: the first carbapenem antibiotic.
Lyon JA
Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
[TBL] [Abstract][Full Text] [Related]
19. Imipenem/cilastatin for pediatric infections in hospitalized patients.
Nalin DR; Hart CB; Shih WJ; Aziz MA
Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
[TBL] [Abstract][Full Text] [Related]
20. Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections.
Fan W; del Busto R; Love M; Markowitz N; Cendrowski C; Cardenas J; Quinn E; Saravolatz L
Antimicrob Agents Chemother; 1986 Jan; 29(1):26-9. PubMed ID: 3460521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
